Flagship Pioneering as of March 31, 2022
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 13 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 71.1 | $3.0B | 18M | 172.26 | |
| Sana Biotechnology (SANA) | 6.6 | $283M | 34M | 8.26 | |
| Rubius Therapeutics | 5.0 | $212M | 39M | 5.51 | |
| Foghorn Therapeutics (FHTX) | 4.5 | $193M | 13M | 15.23 | |
| Omega Therapeutics (OMGAQ) | 3.8 | $162M | 26M | 6.24 | |
| Seres Therapeutics | 2.4 | $102M | 14M | 7.12 | |
| Denali Therapeutics (DNLI) | 2.0 | $84M | 2.6M | 32.17 | |
| Evelo Biosciences | 1.8 | $78M | 23M | 3.39 | |
| Axcella Health Inc equity | 1.1 | $49M | 19M | 2.57 | |
| Kaleido Biosciences Ord (KLDO) | 0.8 | $32M | 20M | 1.65 | |
| Codiak Biosciences | 0.4 | $16M | 2.6M | 6.27 | |
| Sigilon Therapeutics | 0.4 | $15M | 10M | 1.47 | |
| Syros Pharmaceuticals | 0.1 | $3.5M | 2.9M | 1.19 |
